Hyperlipidemia and statins use for the risk of new-onset anxiety/depression in patients with head and neck cancer: A population-based study

doi:10.1371/journal.pone.0174574

Chia Nan University of Pharmacy & Science Institutional Repository > 藥理學院 > 藥學系(所) > 期刊論文 > Item 310902800/31760

請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/31760

標題:	Hyperlipidemia and statins use for the risk of new-onset anxiety/depression in patients with head and neck cancer: A population-based study
作者:	Huang, Chung-I Lin, Li-Ching Tien, Hung-Cheng Que, Jenny Ting, Wei Chen Chen, Po-Chun Wu, Hsin-Min Ho, Chung-Han Wang, Jhi-Joung Wang, Ren-Hong Yang, Ching-Chieh
貢獻者:	E Da Canc Hosp, Dept Radiat Oncol Chi Mei Med Ctr, Dept Radiat Oncol Minist Hlth & Welf, Pingtung Hosp, Dept Psychiat Pingtung Christian Hosp, Dept Radiat Oncol Natl Cheng Kung Univ, Dept Publ Hlth, Coll Med,Natl Cheng Kung Univ Hosp Chi Mei Med Ctr, Dept Med Res Chia Nan Univ Pharm & Sci, Dept Pharm Chi Mei Med Ctr, Dept Clin Pathol Chung Hwa Univ Med Technol, Dept Med Lab Sci & Biotechnol Natl Sun Yat Sen Univ, Inst Biomed Sci Chia Nan Univ Pharm & Sci, Dept Biotechnol
關鍵字:	Quality-Of-Life Cardiovascular-Disease Metabolic Syndrome Depression Anxiety Inflammation Metaanalysis Mortality Symptoms
日期:	2017-03-31
上傳時間:	2018-11-30 15:55:40 (UTC+8)
出版者:	Public Library Science
摘要:	Objective Anxiety/depression is common among patients with head and neck cancer (HNC), and can negatively affect treatment compliance and outcome. The aim of this study was to assess the association between hyperlipidemia and the risk of new-onset anxiety/depression after the diagnosis of HNC and the influence of administering statins. Methods A matched longitudinal cohort study of 1632 subjects (408 HNC patients with preexisting hyperlipidemia and 1224 age- and sex-matched HNC patients without hyperlipidemia) was included and analyzed by using data from Taiwan's National Health Insurance Research Database from January 1996 to December 2012. The incidence and hazard ratios (HRs) for the development of new-onset anxiety/depression were examined between the two groups. Cox proportional hazard regression was applied to estimate the relative risks of anxiety/depressive disorders adjusted for potential confounding factors. To estimate the risks of anxiety/depression in different sub-groups, a stratified analysis was also used. Results HNC patients with preexisting hyperlipidemia had a higher risk for comorbidities such as hypertension, diabetes mellitus, and cardiovascular disease (P <0.001). The incidence rate of anxiety/depression in the HNC patients with preexisting hyperlipidemia was also significantly higher than that among patients without hyperlipidemia (10.78% vs 7.27%, respectively; P = 0.03). A Cox regression model revealed that preexisting hyperlipidemia was an independent risk factor for anxiety/depression (aHR, 1.96; 95% CI, 1.30-2.94). Statins use was protective against anxiety/depression among HNC patients with hyperlipidemia ( aHR, 0.85; 95% CI, 0.46-1.57), especially for individuals older than 65 years and for females. Conclusions Preexisting hyperlipidemia was associated with increased risk of new-onset anxiety/depression in the HNC patients. Statins use for HNC patients with hyperlipidemia could decrease the risk of anxiety/depression, especially for those older than 65 years and for female patients.
關聯:	Plos One, v.12, n.3, e0174574
顯示於類別:	[藥學系(所)] 期刊論文

文件中的檔案:

檔案	描述	大小	格式	瀏覽次數
index.html		0Kb	HTML	1402	檢視/開啟
journal.pone.0174574.pdf		1032Kb	Adobe PDF	0	檢視/開啟

在CNU IR中所有的資料項目都受到原著作權保護.

TAIR相關文章

資料載入中.....